Glutamate carboxypeptidase II (GCPII) inhibitor displays anti-glutamate and anti-cocaine effects in an invertebrate assay

Amino Acids

Volumn 42, Issue 6, 2012, Pages 2521-2524

  Tallarida, Chris ^a   Song, Kevin ^a   Raffa, Robert B ^a   Rawls, Scott M ^a,b  

^a Temple University Health Sciences Center   (United States)

^b TEMPLE UNIVERSITY   (United States)

Author keywords

2 PMPA; Cocaine; GCPII; Glutamate; NMDA; Pilocarpine; Planaria; Stereotypy

Indexed keywords

2 (PHOSPHONOMETHYL)PENTANEDIOIC ACID; COCAINE; DRUGS USED IN THE TREATMENT OF ADDICTION; GLUTAMATE CARBOXYPEPTIDASE II INHIBITOR; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID; PILOCARPINE; UNCLASSIFIED DRUG;

ANTICOCAINE EFFECT; ANTIGLUTAMATE EFFECT; ARTICLE; BEHAVIOR; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG EFFECT; HYPERKINESIA; INVERTEBRATE; NONHUMAN; PRIORITY JOURNAL; STEREOTYPY;

ANIMALS; COCAINE; GLUTAMATE CARBOXYPEPTIDASE II; GLUTAMIC ACID; MODELS, ANIMAL; N-METHYLASPARTATE; ORGANOPHOSPHORUS COMPOUNDS; PILOCARPINE; PLANARIANS; STEREOTYPED BEHAVIOR;

INVERTEBRATA; PLANARIA; TURBELLARIA;

EID: 84862772930     PISSN: 09394451     EISSN: 14382199     Source Type: Journal    
DOI: 10.1007/s00726-011-1052-6     Document Type: Article

References (20)

1. KS Eriksson P Panula 1994 gamma-Aminobutyric acid in the nervous system of a planarian J Comp Neurol 345 528 536 7962699 10.1002/cne.903450405 1:CAS:528:DyaK2cXlslGmtrk%3D
2. T Kusayama S Watanabe 2000 Reinforcing effects of methamphetamine in planarians Neuroreport 11 2511 2513 10943713 10.1097/00001756-200008030-00033 1:CAS:528:DC%2BD3cXlvFynt7g%3D
3. J Nagel I Belozertseva S Greco V Kashkin A Malyshkin A Jirgensons E Shekunova B Eilbacher A Bespalov W Danysz 2006 Effects of NAAG peptidase inhibitor 2-PMPA in model chronic pain-relation to brain concentration Neuropharmacology 51 1163 1171 16926034 10.1016/j.neuropharm.2006.07.018 1:CAS:528:DC%2BD28Xht1ertrbE
4. JH Neale RT Olszewski LM Gehl B Wroblewska T Bzdega 2005 The neurotransmitter N-acetylaspartylglutamate in models of pain, ALS, diabetic neuropathy, CNS injury and schizophrenia Trends Pharmacol Sci 26 477 484 16055199 1:CAS:528:DC%2BD2MXpslCgsLg%3D
5. K Nishimura Y Kitamura T Taniguchi K Agata 2010 Analysis of motor function modulated by cholinergic neurons in planarian Dugesia japonica Neuroscience 168 18 30 20338223 10.1016/j.neuroscience.2010.03.038 1:CAS:528:DC%2BC3cXmtFertL8%3D
6. OR Pagán AL Rowlands M Azam KR Urban AH Bidja DM Roy RB Feeney LK Afshari 2008 Reversal of cocaine-induced planarian behavior by parthenolide and related sesquiterpene lactones Pharmacol Biochem Behav 89 160 170 18222535 10.1016/j.pbb.2007.12.008
7. G Palladini S Ruggeri F Stocchi MF De Pandis G Venturini V Margotta 1996 A pharmacological study of cocaine activity in planaria Comp Biochem Physiol C Pharmacol Toxicol Endocrinol 115 41 45 8983168 10.1016/S0742-8413(96)00053-9 1:STN:280:DyaK2s7jslygsw%3D%3D
8. Raffa RB, Rawls SM (2008) A model for drug action and abuse. Landes Bioscience, Austin
9. RB Raffa JM Valdez 2001 Cocaine withdrawal in planaria Eur J Pharmacol 430 143 145 11698074 10.1016/S0014-2999(01)01358-9 1:CAS:528: DC%2BD3MXotFWhsrY%3D
10. SM Rawls T Thomas M Adeola T Patil N Raymondi A Poles M Loo RB Raffa 2009 Topiramate antagonizes NMDA- and AMPA-induced seizure-like activity in planarians Pharmacol Biochem Behav 93 363 367 19447129 10.1016/j.pbb.2009.05.005 1:CAS:528:DC%2BD1MXpt1Kru7w%3D
11. SM Rawls F Karaca I Madhani V Bhojani RL Martinez M Abou-Gharbia RB Raffa 2010 β-lactamase inhibitors display anti-seizure properties in an invertebrate assay Neuroscience 169 1800 1804 20600649 10.1016/j.neuroscience. 2010.06.041 1:CAS:528:DC%2BC3cXpvFSksLw%3D
12. AL Rowlands OR Pagán 2008 Parthenolide prevents the expression of cocaine-induced withdrawal behavior in planarians Eur J Pharmacol 583 170 172 18275955 10.1016/j.ejphar.2008.01.012 1:CAS:528:DC%2BD1cXivVejsrg%3D
13. BS Slusher JJ Vornov AG Thomas PD Hurn I Harukuni A Bhardwaj RJ Traystman MB Robinson P Britton XC Lu FC Tortella KM Wozniak M Yudkoff BM Potter PF Jackson 1999 Selective inhibition of NAALADase, which converts NAAG to glutamate, reduces ischemic brain injury Nat Med 5 1396 1402 10581082 10.1038/70971 1:CAS:528:DyaK1MXnvFGjsLc%3D
14. BS Slusher A Thomas M Paul CA Schad CR Ashby Jr 2001 Expression and acquisition of the conditioned place preference response to cocaine in rats is blocked by selective inhibitors of the enzyme N-acetylated-alpha-linked-acidic dipeptidase (NAALADASE) Synapse 41 22 28 11354010 10.1002/syn.1056 1:CAS:528:DC%2BD3MXjvF2is74%3D
15. AG Thomas A Bodner G Ghadge RP Roos BS Slusher 2009 GCP II inhibition rescues neurons from gp120IIIB-induced neurotoxicity J Neurovirol 15 449 457 19995130 10.3109/13550280903350598 1:CAS:528:DC%2BC3cXlt12mt7k%3D
16. AK Urazaev RM Grossfeld EM Lieberman 2005 Regulation of glutamate carboxypeptidase II hydrolysis of N-acetylaspartylglutamate (NAAG) in crayfish nervous tissue is mediated by glial glutamate and acetylcholine receptors J Neurochem 93 605 610 15836619 10.1111/j.1471-4159.2005.03041.x 1:CAS:528:DC%2BD2MXktFKgtbk%3D
17. CA Vyas SM Rawls RB Raffa JG Shackman 2011 Glutamate and aspartate measurements in individual planaria by rapid capillary electrophoresis J Pharmacol Toxicol Methods 63 199 222 10.1016/j.vascn.2010.08.002
18. JM Witkin M Gasior C Schad A Zapata T Shippenberg T Hartman BS Slusher 2002 NAALADase (GCP II) inhibition prevents cocaine-kindled seizures Neuropharmacology 43 348 356 12243764 10.1016/S0028-3908(02)00124-7 1:CAS:528:DC%2BD38XntVWnsLw%3D
19. ZX Xi X Li XQ Peng J Li L Chun EL Gardner AG Thomas BS Slusher CR Ashby Jr 2010 Inhibition of NAALADase by 2-PMPA attenuates cocaine-induced relapse in rats: a NAAG-mGluR2/3-mediated mechanism J Neurochem 112 564 576 19895667 10.1111/j.1471-4159.2009.06478.x 1:CAS:528:DC%2BC3cXhtVGisrc%3D
20. ZX Xi M Kiyatkin X Li XQ Peng A Wiggins K Spiller J Li EL Gardner 2010 N-acetylaspartylglutamate (NAAG) inhibits intravenous cocaine self-administration and cocaine-enhanced brain-stimulation reward in rats Neuropharmacology 58 304 313 19559037 10.1016/j.neuropharm.2009.06.016 1:CAS:528:DC%2BD1MXhtlGitrbF